Zoekresultaten - 43 results
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.
https://www.sciensano.be/nl/biblio/eurogin-2011-roadmap-prevention-and-treatment-hpv-related-disease
Primary Prevention Secondary Prevention Uterine Cervical Neoplasms Vulvar Neoplasms Abstract: The EUROGIN 2011 roadmap reviews the current burden of human papillomavirus (HPV)-related morbidity, as well as ...
Highlights of the 27th International Papillomavirus Conference and Clinical Workshop (Berlin, 17-22 September 2011)- Part 2: Applied Clinical Science
alternative anal antibodies assessment cancer Cervical cervical cancer CERVICAL-CANCER cervix Clinical Colposcopy conference disease Dna ECCG health HPV HPV-AHEAD immunology INFECTION infections International ...
Liquid-based cervical cytology using ThinPrep technology: weighing the pros and cons in a cost-effectiveness analysis
Evaluating Follow up FOLLOW-UP HPV Human implementation IS Less Life method methods MODEL monolayer cytology Netherlands ON PREHDICT Quality Quality of Life RCT Research result results SCREENING SENSITIVITY ...
The thickness and volume of LLETZ specimens can predict the relative risk of pregnancy-related morbidity
Number 691, p.685- 691 (2012) Keywords: age an analysis AS association at Belgium birth Brussels cancer Case cervix CI cit_Marbyn complications criteria data Design effect FNRS health hospital HPV Increase ...
Prevention of human papillomavirus-related malignancies of the female genital tract
Publication Type: Peer reviewed scientific article Authors: Koliopoulos,G.; M. Arbyn Source: Infect.Dis.Obstet.Gynecol., Volume 2011 (2012) Keywords: cancer cervix cit_Marbyn epub Female HPV Human ...
Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
European countries health HPV Human IS LEVEL levels Life measure measures medical MODEL Netherlands objectives ON outcome POLICIES POLICY POPULATION PREHDICT prevalence primary screening public public health ...
Cervical cytology biobanks as a resource for molecular epidemiology.
can contribute in answering questions on the natural history of HPV infection and HPV-induced lesions and cancers, screening effectiveness, exploration of new biomarkers, and surveillance of short- and ...
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Keywords: clinical efficacy immunogenicity prophylactic HPV vaccines Abstract: This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the immunogenicity, ...
Introduction of human papillomavirus vaccination in Belgium, Luxembourg and the Netherlands.
Cervical Diseases Uterine Cervical Neoplasms Abstract: AIMS: To document progress with human papillomavirus (HPV) vaccine introduction in three closely related European countries, one with organized (the ...
Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008.
of human papillomavirus (HPV) vaccine introduction in Belgium. Information on vaccine use is based on sales statistics and reimbursement claims. From November 2007 to November 2008, the National ...